Invasive group A streptococcal disease and association with varicella in Germany, 1996-2009

FEMS Immunology and Medical Microbiology

Volumn 62, Issue 1, 2011, Pages 101-109

  Imöhl, Matthias ^a   van der Linden, Mark ^a   Reinert, Ralf René ^a   Ritter, Klaus ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Chickenpox; Invasive infections; Streptococcus pyogenes; Varicella

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; LEVOFLOXACIN; PENICILLIN G; SUPERANTIGEN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHICKENPOX; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; EMM GENE; FEMALE; GERMANY; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INFANT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; SHOCK; TISSUE NECROSIS; TOXIC SHOCK SYNDROME;

ANTI-BACTERIAL AGENTS; CHICKENPOX; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 79955027676     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00788.x     Document Type: Article

References (85)

1. Andersen MM & Ronne T (1995) Group A streptococcal bacteraemias in Denmark 1987-89. J Infection 31: 33-37.
2. Arvand M, Hoeck M, Hahn H & Wagner J (2000) Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin. J Antimicrob Chemoth 46: 621-624.
3. Bassetti M, Manno G, Collida A, Ferrando A, Gatti G, Ugolotti E, Cruciani M & Bassetti D (2000) Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 6: 180-183.
4. Bingen E, Bidet P, Mihaila-Amrouche L, Doit C, Forcet S, Brahimi N, Bouvet A & Cohen R (2004) Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Ch 48: 3559-3562.
5. Brandt CM, Schweizer KG, Holland R, Lutticken R & Freyaldenhoven BS (2005) Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections. Int J Med Microbiol 295: 539-546.
6. Cameron JC, Allan G, Johnston F, Finn A, Heath PT & Booy R (2007) Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 92: 1062-1066.
7. Carapetis JR, Steer AC, Mulholland EK & Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685-694.
8. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR & Schlievert PM (1992) Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339: 518-521.
9. Clinical Laboratory Standards Institute (2009) Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Clinical Laboratory Standards Institute, Wayne, PA.
10. Creti R, Imperi M, Baldassarri L, Pataracchia M, Recchia S, Alfarone G & Orefici G (2007) emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol 45: 2249-2256.
11. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
12. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalen C, Norgren M, Romanus V, Norrby-Teglund A & Normark BH (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45: 450-458.
13. Davies HD, Matlow A, Scriver SR, Schlievert P, Lovgren M, Talbot JA & Low DE (1994) Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 13: 49-56.
14. De Azavedo JC, Yeung RH, Bast DJ, Duncan CL, Borgia SB & Low DE (1999) Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Ch 43: 2144-2147.
15. Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, Walmsley S & Low DE (1993) Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 16: 792-800; discussion 801-802.
16. Descheemaeker P, Van Loock F, Hauchecorne M, Vandamme P & Goossens H (2000) Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994. J Med Microbiol 49: 467-471.
17. Efstratiou A, Emery M, Lamagni TL, Tanna A, Warner M & George RC (2003) Increasing incidence of group A streptococcal infections amongst injecting drug users in England and Wales. J Med Microbiol 52: 525-526.
18. Ekelund K, Skinhoj P, Madsen J & Konradsen HB (2005) Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J Clin Microbiol 43: 1789-1796.
19. Eriksson BK, Andersson J, Holm SE & Norgren M (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180: 410-418.
20. Falcone PA, Pricolo VE & Edstrom LE (1988) Necrotizing fasciitis as a complication of chickenpox. Clin Pediatr 27: 339-343.
21. Fraser JD & Proft T (2008) The bacterial superantigen and superantigen-like proteins. Immunol Rev 225: 226-243.
22. Gene A, Ardanuy C, Palacin E & Garcia-Garcia JJ (2006) Increasing methylase-mediated resistance to macrolides in Streptococcus pyogenes in a children's hospital in Barcelona (Spain). Enferm Infec Micr Cl 24: 26-28.
23. Giovanetti E, Montanari MP, Mingoia M & Varaldo PE (1999) Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Ch 43: 1935-1940.
24. Granizo JJ, Aguilar L, Casal J, Dal-Re R & Baquero F (2000) Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemoth 46: 959-964.
25. Haukness HA, Tanz RR, Thomson RB Jr, Pierry DK, Kaplan EL, Beall B, Johnson D, Hoe NP, Musser JM & Shulman ST (2002) The heterogeneity of endemic community pediatric group a streptococcal pharyngeal isolates and their relationship to invasive isolates. J Infect Dis 185: 915-920.
26. Holm SE, Norrby A, Bergholm AM & Norgren M (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 166: 31-37.
27. Hutchinson J (1882) On gangrenous eruptions in connection with vaccination and chickenpox. Med Chir Trans 65: 1-11.
28. Ikebe T, Hirasawa K, Suzuki R et al. (2005) Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections. Antimicrob Agents Ch 49: 788-790.
29. Ikebe T, Hirasawa K, Suzuki R et al. (2007) Distribution of emm genotypes among group A streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001-2005. Epidemiol Infect 135: 1227-1229.
30. Imöhl M, Reinert RR, Ocklenburg C & van der Linden M (2010) Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Mic 58: 389-396.
31. Iwasaki T, Muraki R, Kasahara T, Sato Y, Sata T & Kurata T (2001) Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens. Arch Virol 17 (suppl): 109-119.
32. Katz AR & Morens DM (1992) Severe streptococcal infections in historical perspective. Clin Infect Dis 14: 298-307.
33. Kiska DL, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan EL, Gruninger RP, Lohr JA, Gilligan PH & Denny FW Jr (1997) Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 176: 992-1000.
34. Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A & Schalen C (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 10: 179-184.
35. Laupland KB, Davies HD, Low DE, Schwartz B, Green K & McGeer A (2000) Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 105: E60.
36. Lin YH, Huang LM, Chang IS, Tsai FY & Chang LY (2009) Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005. J Microbiol Immunol Infect 42: 5-12.
37. Lintges M, van der Linden M, Hilgers RD, Arlt S, Al-Lahham A, Reinert RR, Plucken S & Rink L (2010) Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection. J Infect Dis 202: 20-28.
38. Lloyd CA, Jacob SE & Menon T (2007) Antibiotic resistant beta-hemolytic streptococci. Indian J Pediatr 74: 1077-1080.
39. Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM & Jasir A (2008) Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 46: 79-86.
40. Martin PR & Hoiby EA (1990) Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 22: 421-429.
41. Meyer PA, Seward JF, Jumaan AO & Wharton M (2000) Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 182: 383-390.
42. Muraki R, Baba T, Iwasaki T, Sata T & Kurata T (1992) Immunohistochemical study of skin lesions in herpes zoster. Virchows Arch A 420: 71-76.
43. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K & Selander RK (1991) Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. P Natl Acad Sci USA 88: 2668-2672.
44. Nakae M, Murai T, Kaneko Y & Mitsuhashi S (1977) Drug resistance in Streptococcus pyogenes isolated in Japan. Antimicrob Agents Ch 12: 427-428.
45. Nikkels AF & Pierard GE (2003) Necrotizing varicella zoster virus folliculitis. Eur J Dermatol 13: 587-589.
46. Norton R, Smith HV, Wood N, Siegbrecht E, Ross A & Ketheesan N (2004) Invasive group A streptococcal disease in North Queensland (1996-2001). Indian J Med Res 119 (suppl): 148-151.
47. O'Brien KL, Beall B, Barrett NL et al. (2002) Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 35: 268-276.
48. O'Grady KA, Kelpie L, Andrews RM, Curtis N, Nolan TM, Selvaraj G, Passmore JW, Oppedisano F, Carnie JA & Carapetis JR (2007) The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Med J Australia 186: 565-569.
49. O'Loughlin RE, Roberson A, Cieslak PR et al. (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 45: 853-862.
50. Patel RA, Binns HJ & Shulman ST (2004) Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. J Pediatr 144: 68-74.
51. Paul E & Thiel T (1996) Epidemiology of varicella zoster infection. Results of a prospective study in the Ansbach area. Hautarzt 47: 604-609.
52. Perez-Trallero E, Urbieta M, Montes M, Ayestaran I & Marimon JM (1998) Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol 17: 25-31.
53. Perez-Trallero E, Montes M, Orden B, Tamayo E, Garcia-Arenzana JM & Marimon JM (2007) Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Ch 51: 1228-1233.
54. Peterson CL, Vugia DJ, Meyers HB, Chao SM, Vogt J, Lanson J, Brunell PA, Kim KS & Mascola L (1996) Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J 15: 151-156.
55. Podbielski A, Melzer B & Lütticken R (1991) Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci. Med Microbiol Immun 180: 213-227.
56. Preblud SR (1986) Varicella: complications and costs. Pediatrics 78: 728-735.
57. Requena L & Requena C (2010) Histopathology of the more common viral skin infections. Actas Dermosifiliogr 101: 201-216.
58. Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H & Doern GV (2008) Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J Antimicrob Chemoth 61: 603-611.
59. Rivera A, Rebollo M, Miro E, Mateo M, Navarro F, Gurgui M, Mirelis B & Coll P (2006) Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 55: 1115-1123.
60. Rivest P, Bedard L, Valiquette L, Mills E, Lebel MH, Lavoie G & Carsley J (2001) Severe complications associated with varicella: province of Quebec, April 1994 to March 1996. Can J Infect Dis 12: 21-26.
61. Rogers S, Commons R, Danchin MH, Selvaraj G, Kelpie L, Curtis N, Robins-Browne R & Carapetis JR (2007) Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. J Infect Dis 195: 1625-1633.
62. Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC, Hafner D & Novak R (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188: 1578-1586.
63. Sloan DS & Burlison A (1992) Shift in age in chickenpox. Lancet 340: 974.
64. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM & Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. New Engl J Med 321: 1-7.
65. Stromberg A, Romanus V & Burman LG (1991) Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 164: 595-598.
66. Suwabe H, Yabe H & Tsutsumi Y (1996) Relapsing hemorrhagic varicella. Pathol Int 46: 605-609.
67. Szczypa K, Sadowy E, Izdebski R, Strakova L & Hryniewicz W (2006) Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol 44: 3975-3979.
68. Talkington DF, Schwartz B, Black CM, Todd JK, Elliott J, Breiman RF & Facklam RR (1993) Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 61: 3369-3374.
69. Tamayo J, Perez-Trallero E, Gomez-Garces JL & Alos JI (2005) Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J Antimicrob Chemoth 56: 780-782.
70. Tanaka K, Tsuda S & Sasai Y (1994) Scanning and transmission electron microscopic studies of lesional epidermis in herpes zoster. J Dermatol 21: 560-570.
71. Tsukahara T & Horiuchi Y (1996) Immunohistochemical study of cellular events in lesional skin during common virus infections. J Dermatol 23: 22-32.
72. Tyrrell GJ, Lovgren M, Kress B & Grimsrud K (2005) Varicella-associated invasive group A streptococcal disease in Alberta, Canada - 2000-2002. Clin Infect Dis 40: 1055-1057.
73. Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ & Kim HY (2004) Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Antimicrob Agents Ch 48: 2716-2718.
74. Ulloa-Gutierrez R, Dobson S & Forbes J (2005) Group A streptococcal subdural empyema as a complication of varicella. Pediatrics 115: e112-e114.
75. Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, Roth SJ, Tait VF, Thompson JA, Daly JA & Kaplan EL (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. New Engl J Med 316: 421-427.
76. Veien NK (1978) Cytologic examination and viral and bacterial culture in herpes simplex, herpes zoster, and varicella. Cutis 22: 61-64.
77. Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC, Novak R, Verhoef J & Schmitz FJ (2003) Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41: 4941-4949.
78. Vlaminckx BJ, van Pelt W, Schouls LM, van Silfhout A, Mascini EM, Elzenaar CP, Fernandes T, Bosman A & Schellekens JF (2005) Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003. Clin Microbiol Infec 11: 226-231.
79. Vugia DJ, Peterson CL, Meyers HB, Kim KS, Arrieta A, Schlievert PM, Kaplan EL & Werner SB (1996) Invasive group A streptococcal infections in children with varicella in Southern California. Pediatr Infect Dis J 15: 146-150.
80. Wahl RU, Lütticken R, Stanzel S, van der Linden M & Reinert RR (2007) Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system. Clin Microbiol Infec 13: 1173-1178.
81. Weber P, Filipecki J, Bingen E, Fitoussi F, Goldfarb G, Chauvin JP, Reitz C & Portier H (2001) Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemoth 48: 291-294.
82. Wilson GJ, Talkington DF, Gruber W, Edwards K & Dermody TS (1995) Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis 20: 1333-1338.
83. Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269: 390-391.
84. Ziebold C, von Kries R, Lang R, Weigl J & Schmitt HJ (2001) Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 108: E79.
85. Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam R, Schwartz B & Farley MM (1998) Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis 27: 150-157.